Aclidinium Bromide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

AMPLIFY - D6571C00001 Duaklir USA Phase III Study
Condition:   Chronic Obstructive Pulmonary DiseaseInterventions:   Drug: Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg);   Drug: Aclidinium bromide 400 μg (AB 400 μg);   Drug: Formoterol fumarate 12 μg (FF 12 μg);   Drug: Placebo to AB/FF 400/12 μg, AB 400 μg and FF 12 μg;   Drug: Tiotropium 18 μg (TIO 18 μg);   Drug: Placebo to TIO 18 μgSponsor:   AstraZenecaNot yet recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2016 Category: Research Source Type: clinical trials